Profile
David LaPré is currently a Non-Executive Director at Hovione Farmaciência SA and the President of Dgl Advisors LLC.
He previously worked as a Director at Calidi Biotherapeutics, Inc. Mr. LaPré holds an MBA from New York University and an undergraduate degree from Worcester Polytechnic Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-25 | 0 ( -.--% ) | - $ | 2024-06-29 |
David LaPré active positions
| Companies | Position | Start |
|---|---|---|
Hovione Farmaciência SA
 Hovione Farmaciência SA Pharmaceuticals: MajorHealth Technology Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal. | Director/Board Member | - |
Former positions of David LaPré
| Companies | Position | End |
|---|---|---|
| CALI BIOTPAR | Director/Board Member | 2024-05-09 |
Training of David LaPré
| Worcester Polytechnic Institute | Undergraduate Degree |
| New York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CALI BIOTPAR | Health Technology |
| Private companies | 1 |
|---|---|
Hovione Farmaciência SA
Hovione Farmaciência SA Pharmaceuticals: MajorHealth Technology Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal. | Health Technology |
- Stock Market
- Insiders
- David LaPré
